Sustained innovation in medical devices depends on dedicated research infrastructure and a defensible intellectual property position. This overview summarizes INVAMED's research and development center, INVAcenter, and the patent portfolio that underpins the company's device engineering, for distributors, industry partners, and technically oriented readers evaluating INVAMED's innovation capacity.
What Is INVAcenter?
INVAcenter is INVAMED's dedicated research and development center, based at the company's 15,000 m² manufacturing campus in Ankara, Turkey. As the hub for the company's device engineering work, INVAcenter supports the technical development activities behind INVAMED's portfolio of more than 150 medical devices, drawing on the expertise of the company's team of more than 200 specialists.
Having a centralized R&D function co-located with manufacturing allows engineering, quality, and production teams to work closely together as devices move from design concept through development and into validated manufacturing processes.
What Does INVAMED's Patent Portfolio Represent?
INVAMED holds more than 100 international patents, a portfolio reflecting the company's ongoing investment in original device engineering since its founding in 2005. A substantial patent position is generally understood in the medical device industry as an indicator of sustained investment in proprietary technology development, as opposed to a business model built solely on replicating existing designs.
For distributors and institutional partners, a manufacturer's patent portfolio can be a relevant reference point when assessing organizational maturity and long-term technology investment, alongside more directly operational criteria such as regulatory certification and manufacturing capacity.
How Does R&D Investment Connect to INVAMED's Product Portfolio?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Why Does R&D Capacity Matter to Distribution and Procurement Partners?
For businesses considering a distribution partnership, or institutions evaluating a manufacturer for long-term supply relationships, a manufacturer's demonstrated R&D infrastructure and patent activity can suggest capacity for continued product development and portfolio expansion over time — relevant considerations for partners planning multi-year relationships rather than one-time purchases. Organizations interested in learning more about INVAMED's technology development or specific device engineering can reach out through the company's Contact page.
Frequently Asked Questions
How many patents does INVAMED currently hold?
INVAMED holds more than 100 international patents across its technology areas, reflecting the company's ongoing device engineering investment since its 2005 founding.
Where is INVAMED's R&D center located?
INVAcenter, INVAMED's dedicated research and development center, is based at the company's manufacturing campus in Ankara, Turkey.
Can industry partners request more information about INVAMED's R&D capabilities?
Yes. Inquiries regarding INVAMED's research, development, and technology capabilities can be submitted through the company's Contact page.
Related INVAMED Resources
- Explore INVAMED's Neurovascular Interventions product category
- Read our guide to INVAMED Company Profile: A Global Medical Device Manufacturer
- Learn about How to Choose a Medical Device Manufacturer
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.